Heron Therapeutics Inc (NASDAQ:HRTX)

BATS BZX Real-Time Price
As of 2:00pm ET
 +0.60 / +2.01%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 39.00, with a high estimate of 56.00 and a low estimate of 30.00. The median estimate represents a +28.08% increase from the last price of 30.45.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 41.65%
Growthannually 31.55%


Growthquarterly 7.66%
Growthannually 123.45%
Key to the earnings and sales forecast charts.